References
- ErramSVFanskaCBAsifMDetermination of albuterol sulfate and its related substances in albuterol sulfate inhalation solution, 0.5% by RP-HPLCJ Pharm Biomed Anal200640486487416243471
- NewmanSPBusseWWEvolution of dry powder inhaler design, formulation, and performanceRespir Med200296529330412113378
- SungJCPulliamBLEdwardsDANanoparticles for drug delivery to the lungsTrends Biotechnol2007251256357017997181
- WoodsAPatelASpinaDIn vivo biocompatibility, clearance, and biodistribution of albumin vehicles for pulmonary drug deliveryJ Control Release20152101925980621
- DasPJPaulPMukherjeeBPulmonary delivery of voriconazole loaded nanoparticles providing a prolonged drug level in lungs: a promise for treating fungal infectionMol Pharm20151282651266425941882
- KimKJMalikABProtein transport across the lung epithelial barrierAm J Physiol Lung Cell Mol Physiol20032842L247L25912533309
- ChoiSHByeonHJChoiJSInhalable self-assembled albumin nanoparticles for treating drug-resistant lung cancerJ Control Release201519719920725445703
- SeoJLeeCHwangHSTherapeutic advantage of inhaled tacrolimus-bound albumin nanoparticles in a bleomycin-induced pulmonary fibrosis mouse modelPulm Pharmacol Ther201636536126768967
- LuoQWangYYangHModeling the interaction of interferon α-1b to bovine serum albumin as a drug delivery systemJ Phys Chem B2014118298566857424988473
- VallianatouTLambrinidisGTsantili-KakoulidouAIn silico prediction of human serum albumin binding for drug leadsExpert Opin Drug Discov20138558359523461733
- AlbersJAllesRMatthéeKKnopKNahrupJSKleinebuddePMechanism of drug release from polymethacrylate-based extrudates and milled strands prepared by hot-melt extrusionEur J Pharm Biopharm200971238739418951978
- SripriyalakshmiSAnjaliCHGeorgePDRajithBRavindranABSA nanoparticle loaded atorvastatin calcium: a new facet for an old drugPLoS One201492e8631724498272
- ShooshtarySBehtashSNafisiSArsenic trioxide binding to serum proteinsJ Photochem Photobiol B2015148313625863441
- PengXQiWHuangRSuRHeZElucidating the influence of gold nanoparticles on the binding of salvianolic acid B and rosmarinic acid to bovine serum albuminPLoS One2015104e011827425861047
- GhoshKRathiSAroraDFluorescence spectral studies on interaction of fluorescent probes with bovine serum albumin (BSA)J Lumin2016175135140
- ZhangXLiLXuZInvestigation of the interaction of naringin palmitate with bovine serum albumin: spectroscopic analysis and molecular dockingPLoS One201383e5910623527100
- FuriniSDomeneCComputational studies of transport in ion channels using metadynamicsBiochim Biophys Acta201618587 Pt B1733174026891818
- HenseleitAPohlCKaltenbachHMKinetic analyses of data from a human serum albumin assay using the liSPR systemBiosensors (Basel)201551273625607476
- NguyenHHParkJKangSKimMSurface plasmon resonance: a versatile technique for biosensor applicationsSensors (Basel)2015155104811051025951336
- HuYJLiuYSunTQBaiAMLuJQPiZBBinding of anti-inflammatory drug cromolyn sodium to bovine serum albuminInt J Biol Macromol2006394–528028516707156
- TantraRTompkinsJQuinceyPCharacterisation of the de-agglomeration effects of bovine serum albumin on nanoparticles in aqueous suspensionColloids Surf B Biointerfaces201075127528119775871
- HeXMCarterDCAtomic structure and chemistry of human serum albuminNature199235863832092151630489
- MajorekKAPorebskiPJDayalAStructural and immunologic characterization of bovine, horse, and rabbit serum albuminsMol Immunol2012523–417418222677715
- FrischMJTrucksGWSchlegelHBGaussian 03 [software]Wallingford (CT)Gaussian Inc2004
- WangJWolfWRCaldwellJWKollmanPACaseDADevelopment and testing of a general amber force fieldJ Comput Chem20042591157117415116359
- da SilvaAWVrankenWFACPYPE: AntecChamber PYthon Parser interfacEBMC Res Notes2012536722824207
- AbrahamMJMurtolaTSchulzRGROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputersSoftwareX20151–21925
- DuanYWuCChowdhurySA point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculationsJ Comput Chem200324161999201214531054
- JorgensenWLChandrasekharJMaduraJDImpeyRWKleinMLComparison of simple potential functions for simulating liquid waterJ Chem Phys1983792926935
- NoseSA unified formulation of the constant temperature molecular dynamics methodsJ Chem Phys1984811511519
- ParrinelloMRahmanAPolymorphic transitions in single crystals: a new molecular dynamics methodJ Appl Phys1981521271827190
- DardenTYorkDPedersenLParticle mesh Ewald: an N·log(N) method for Ewald sums in large systemsJ Chem Phys199398121008910092
- HessBBekkerHBerendsenHFraaijeJLINCS: a linear constraint solver for molecular simulationsJ Comput Chem1997181214631472
- KumariRKumarRg_mmpbsa: a GROMACS tool for high-throughput MM-PBSA calculationsJ Chem Inf Model20145471951196224850022
- CaseDACheathamTE3rdDardenTThe Amber biomolecular simulation programsJ Comput Chem200526161668168816200636
- HomeyerNGohlkeHFree energy calculations by the molecular mechanics Poisson-Boltzmann surface area methodMol Inform201231211412227476956
- XiaokaitiYWuHChenYEGCG reverses human neutrophil elastase-induced migration in A549 cells by directly binding to HNE and by regulating α1-ATSci Rep201551149426177797
- SatohMSaburiHTanakaTMultiple binding modes of a small molecule to human Keap1 revealed by X-ray crystallography and molecular dynamics simulationFEBS Open Bio20155557570
- LiFQSuHWangJPreparation and characterization of sodium ferulate entrapped bovine serum albumin nanoparticles for liver targetingInt J Pharm20083491–227428217870261
- MerodioMArnedoARenedoMJIracheJMGanciclovir-loaded albumin nanoparticles: characterization and in vitro release propertiesEur J Pharm Sci200112325125911113644
- ZhaoLZhouYGaoYBovine serum albumin nanoparticles for delivery of tacrolimus to reduce its kidney uptake and functional nephrotoxicityInt J Pharm20154831–218018725681723
- VolkamerAKuhnDRippmannFRareyMDoGSiteScorer: a web server for automatic binding site prediction, analysis and druggability assessmentBioinformatics201228152074207522628523
- AwasthiSMuruganNASaraswathiNTAdvanced glycation end products modulate structure and drug binding properties of albuminMol Pharm20151293312332226281017
- SinghASolimanMEUnderstanding the cross-resistance of oseltamivir to H1N1 and H5N1 influenza A neuraminidase mutations using multidimensional computational analysesDrug Des Devel Ther2015941374154
- XiangYDuanLMaQLvZRuohuaZZhangZFluorescence spectroscopy and molecular simulation on the interaction of caffeic acid with human serum albuminLuminescence Epub2016413
- GräterFSchwarzlSMDejaegereAFischerSSmithJCProtein/ligand binding free energies calculated with quantum mechanics/molecular mechanicsJ Phys Chem B200510920104741048316852269
- XuDTsaiCJNussinovRHydrogen bonds and salt bridges across protein-protein interfacesProtein Eng199710999910129464564
- PetukhowMCregutDSoaresCMSerranoLLocal water bridges and protein conformational stabilityProtein Sci19998101982198910548043
- KratzFAlbumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticlesJ Control Release2008132317118318582981
- YuZYuMZhangZHongGXiongQBovine serum albumin nanoparticles as controlled release carrier for local drug delivery to the inner earNanoscale Res Lett20149134325114637
- ElzoghbyAOSamyWMElgindyNAAlbumin-based nanoparticles as potential controlled release drug delivery systemsJ Control Release2012157216818221839127
- NooraniLStenzelMLiangRPourgholamiMHMorrisDLAlbumin nanoparticles increase the anticancer efficacy of albendazole in ovarian cancer xenograft modelJ Nanobiotechnology2015132525890381
- VishnuPRoyVSafety and efficacy of nab-paclitaxel in the treatment of patients with breast cancerBreast Cancer (Auckl)20115536521603258
- BunkerAMagarkarAVilitalaTRational design of liposomal drug delivery systems, a review: combined experimental and computational studies of lipid membranes, liposomes and their PEGylationBiochim Biophys Acta Epub2016223
- YangFZhangYLiangHInteractive association of drugs binding to human serum albuminInt J Mol Sci20141533580359524583848
- JosephKSMoserACBasiagaSBSchielJEHageDSEvaluation of alternatives to warfarin as probes for Sudlow site I of human serum albumin characterization by high-performance affinity chromatographyJ Chromatogr A20091216163492350018926542
- ConradMLMoserACHageDSEvaluation of indole-based probes for high-throughput screening of drug binding to human serum albumin: analysis by high-performance affinity chromatographyJ Sep Sci20093281145115519296478
- SimardJRZunszainPAHaCELocating high-affinity fatty acid-binding sites on albumin by X-ray crystallography and NMR spectroscopyProc Natl Acad Sci U S A200510250179581796316330771
- SimardJRZunszainPAHamiltonJACurrySLocation of high and low affinity fatty acid binding sites on human serum albumin revealed by NMR drug-competition analysisJ Mol Biol2006361233635116844140
- DockalMChangMCarterDCRükerFFive recombinant fragments of human serum albumin: tools for the characterization of the warfarin binding siteProtein Sci2000981455146510975567
- PodaSBKobayashiMNachaneRDevelopment of a surface plasmon resonance assay for the characterization of small-molecule binding kinetics and mechanism of binding to kynurenine 3-monooxygenaseAssay Drug Dev Technol201513846647526292018
- El-GendyNPornputtapitakWBerklandCNanoparticle agglomerates of fluticasone propionate in combination with albuterol sulfate as dry powder aerosolsEur J Pharm Sci201144452253321964203
- MuchãoFPSouzaJMTorresHCAlbuterol via metered-dose inhaler in children: lower doses are effective and higher doses are safePediatr Pulmonol Epub2016512
- EdwardsDAHanesJCaponettiGLarge porous particles for pulmonary drug deliveryScience19972765320186818719188534
- GharseSFiegelJLarge porous hollow particles: lightweight champions of pulmonary drug deliveryCurr Pharm Des201622172463246926818876
- AntonNJakhmolaAVandammeTFTrojan microparticles for drug deliveryPharmaceutics20124112524300177